Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details Textual)

v2.4.0.6
Income Taxes (Details Textual) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Income Taxes (Textual) [Abstract]    
Valuation allowance $ 26,201,000 $ 17,007,000
Prior year state NOL (2.00%) 3.00%
Prior year federal NOL (3.00%)  
State rate change   1.00%
Overstate gross deferred tax assets 3,600,000  
Understate the valuation allowance 3,600,000  
Unrecognized tax benefits 0  
Interest expense or penalties related to unrecognized tax benefits 0  
Extended research credit period 2 years  
Domestic Country [Member]
   
Income Taxes (Textual) [Abstract]    
Net operating loss carryforwards 53,500,000  
State and Local Jurisdiction [Member]
   
Income Taxes (Textual) [Abstract]    
Net operating loss carryforwards 16,800,000  
Research [Member]
   
Income Taxes (Textual) [Abstract]    
Research and development tax credit carryforwards 1,000,000  
Orphan Drug Tax Credit [Member]
   
Income Taxes (Textual) [Abstract]    
Research and development tax credit carryforwards $ 300,000